ESTUTC-5 New YorkLog in Sign up

SRZN
Surrozen, Inc. Common
stockNASDAQ

At CloseNov 13, 2026 3:59:55 PM EST

31.50USD-0.537%(-0.17)106,708

Pre-marketNov 13, 2026 8:00:30 AM EST

31.41USD-0.821%(-0.26)

After-hoursNov 13, 2026 4:00:30 PM EST

31.61USD+0.349%(+0.11)

SRZN News

Day breaks

08:00 AM ESTSurrozen Announces Pricing of $60 Million Underwritten Offering of Common Stock ·

GlobeNewswire Inc.

09:01 AM ESTSRZN Maintains Buy Rating by Guggenheim -- Price Target Raised to $80 ·

GuruFocus

08:05 AM ESTSRZN Maintained by Cantor Fitzgerald -- Price Target Raised to $62 ·

GuruFocus

05:09 AM ESTSurrozen GAAP EPS of -$11.02 misses by $9.92 ·

Seeking Alpha

04:40 PM ESTSurrozen to Present at Upcoming Healthcare Investor Conference ·

GlobeNewswire Inc.

04:59 PM EDTSurrozen Announces Closing of Second Tranche of March 2025 Private Placement for $95.1 Million ·

GlobeNewswire Inc.

08:45 AM EDTSurrozen advances diabetic macular edema candidate into clinic after IND clearance ·

Seeking Alpha

08:00 AM EDTSurrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema ·

GlobeNewswire Inc.

03:17 AM EDTMarket Movers | Winners: SRZN, MNTK, CD | Losers: LRMR, ACAD, SGMT ·

Trefis

05:11 PM EDTSurrozen, Inc. (SRZN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript ·

Seeking Alpha